Global Umbilical cord clamp Industry 2015 Industry Report is Now Available From MarketResearchReports.com

The 'Global and Chinese Umbilical cord clamp Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Umbilical cord clamp industry with a focus on the Chinese market. The report provides key statistics on the market status of the Umbilical cord clamp manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Umbilical cord clamp industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.

The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2015-2020 market development trends of Umbilical cord clamp industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Umbilical cord clamp Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Umbilical cord clamp industry covering all important parameters.

Spanning over 150 pages “Global and Chinese Umbilical cord clamp Industry, 2015 Market Research Report” report covers Introduction of Umbilical cord clamp Industry, Manufacturing Technology of Umbilical cord clamp, Analysis of Global Key Manufacturers, 2010-2015 Global and Chinese Market of Umbilical cord clamp, Market Status of Umbilical cord clamp Industry, 2015-2020 Market Forecast of Global and Chinese Umbilical cord clamp Industry, Analysis of Umbilical cord clamp Industry Chain, Global and Chinese Economic Impact on Umbilical cord clamp Industry, Market Dynamics of Umbilical cord clamp Industry, Proposals for New Project, Research Conclusions of Global and Chinese Umbilical cord clamp Industry.

For further information on this report, please visit- http://mrr.cm/4h

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Global Colostomy bag Industry 2015 Industry Report is Now Available From MarketResearchReports.com

The 'Global and Chinese Colostomy bag Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Colostomy bag industry with a focus on the Chinese market. The report provides key statistics on the market status of the Colostomy bag manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Colostomy bag industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2015-2020 market development trends of Colostomy bag industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Colostomy bag Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Colostomy bag industry covering all important parameters.

Spanning over 150 pages, “Global and Chinese Colostomy bag Industry, 2015 Market Research Report” report covers the Introduction of Colostomy bag Industry, Manufacturing Technology of Colostomy bag, Analysis of Global Key Manufacturers, 2010-2015 Global and Chinese Market of Colostomy bag, Market Status of Colostomy bag Industry, 2015-2020 Market Forecast of Global and Chinese Colostomy bag Industry, Analysis of Colostomy bag Industry Chain, Global and Chinese Economic Impact on Colostomy bag Industry, Market Dynamics of Colostomy bag Industry, Proposals for New Project, Research Conclusions of Global and Chinese Colostomy bag Industry.

For further information on this report, please visit- http://mrr.cm/4h4

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Global Metoprolol Succinate (CAS 98418-47-4) Industry 2015 Industry Report is Now Available From MarketResearchReports.com

The 'Global and Chinese Metoprolol Succinate Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Metoprolol Succinate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Metoprolol Succinate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Metoprolol Succinate industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.

The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2015-2020 market development trends of Metoprolol Succinate industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Metoprolol Succinate Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Metoprolol Succinate industry covering all important parameters.

Spanning over 150 pages “Global and Chinese Metoprolol Succinate (CAS 98418-47-4) Industry, 2015 Market Research Report” report covers Introduction of Metoprolol Succinate Industry, Manufacturing Technology of Metoprolol Succinate, Analysis of Global Key Manufacturers, 2010-2015 Global and Chinese Market of Metoprolol Succinate, Market Status of Metoprolol Succinate Industry, 2015-2020 Market Forecast of Global and Chinese Metoprolol Succinate Industry, Analysis of Metoprolol Succinate Industry Chain, Global and Chinese Economic Impact on Metoprolol Succinate Industry, Market Dynamics of Metoprolol Succinate Industry, Proposals for New Project, Research Conclusions of Global and Chinese Metoprolol Succinate Industry.

For further information on this report, please visit- http://mrr.cm/4hc

Find all Pharmacy Reports at: http://www.marketresearchreports.com/pharmacy

Global Lidocaine Hcl (CAS 6108-05-0) Industry 2015 Industry Report is Now Available From MarketResearchReports.com

The 'Global and Chinese Lidocaine Hcl Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Lidocaine Hcl industry with a focus on the Chinese market. The report provides key statistics on the market status of the Lidocaine Hcl manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Lidocaine Hcl industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2015-2020 market development trends of Lidocaine Hcl industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Lidocaine Hcl Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Lidocaine Hcl industry covering all important parameters.

Spanning over 150 pages, “Global and Chinese Lidocaine Hcl (CAS 6108-05-0) Industry, 2015 Market Research Report” report covers the Introduction of Lidocaine Hcl Industry, Manufacturing Technology of Lidocaine Hcl, Analysis of Global Key Manufacturers, 2010-2015 Global and Chinese Market of Lidocaine Hcl, Market Status of Lidocaine Hcl Industry, 2015-2020 Market Forecast of Global and Chinese Lidocaine Hcl Industry, Analysis of Lidocaine Hcl Industry Chain, Global and Chinese Economic Impact on Lidocaine Hcl Industry, Market Dynamics of Lidocaine Hcl Industry, Proposals for New Project, Research Conclusions of Global and Chinese Lidocaine Hcl Industry.

For further information on this report, please visit- http://mrr.cm/4ny

Find all Pharmacy Reports at: http://www.marketresearchreports.com/pharmacy

Global Insulin Pen Industry 2015 Industry Report is Now Available From MarketResearchReports.com

The 'Global and Chinese Insulin pen Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Insulin pen industry with a focus on the Chinese market. The report provides key statistics on the market status of the Insulin pen manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Insulin pen industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2015-2020 market development trends of Insulin pen industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Insulin pen Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Insulin pen industry covering all important parameters.

Spanning over 150 pages, “Global and Chinese Insulin pen Industry, 2015 Market Research Report” report covers the Introduction of Insulin pen Industry, Manufacturing Technology of Insulin pen, Analysis of Global Key Manufacturers, 2010-2015 Global and Chinese Market of Insulin pen, Market Status of Insulin pen Industry, 2015-2020 Market Forecast of Global and Chinese Insulin pen Industry, Analysis of Insulin pen Industry Chain, Global and Chinese Economic Impact on Insulin pen Industry, Market Dynamics of Insulin pen Industry, Proposals for New Project, Research Conclusions of Global and Chinese Insulin pen Industry.

For further information on this report, please visit- http://mrr.cm/4nC

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Healthcare IT market in Saudi Arabia to grow at a CAGR of 12.28% over the period 2014-2019; Finds New Report

Report forecast the healthcare IT market in Saudi Arabia to grow at a CAGR of 12.28 percent over the period 2014-2019.

Over the years, businesses in Saudi Arabia have been adopting advanced technologies and IT integration solutions to enhance their operations and revenue. With more and more operations being enabled and enriched by innovative IT applications and solutions, IT has become a key enabler of business functions. This trend is also being witnessed in the healthcare sector in Saudi Arabia. The need to maintain a standard record format has led to the transformation of traditional medical records to electronic health records. Implementation of the policy that makes insurance mandatory is also contributing to the growth of this market. The need to track common ailments has also intensified the need for IT. In addition, the inherent benefits of IT, such as process efficiency, cost-effectiveness, mobility, and accessibility are all driving its adoption.

This report provides an overview of the healthcare IT market in Saudi Arabia. The market is segmented into: hardware, software, and services.

According to the report, adoption of technology for operational effectiveness is one of the key drivers in the market. Saudi Arabia is making huge investments in cloud, mobility, virtualization, telemedicine, and remote patient monitoring. These technologies offer various benefits to healthcare solution providers.

Healthcare IT Market in Saudi Arabia 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the healthcare IT market landscape in Saudi Arabia and its growth prospects in the coming years. The report also includes profile of key vendors operating in this market.

Key players in the healthcare IT market in Saudi Arabia: GE Healthcare, Hewlett-Packard Co. (HP), IBM Corp., Intel Corp., InterSystems Corp., Oracle Corp.  and Siemens Healthcare

Other Prominent Vendors in the market are: 3M, Agfa Heathcare, Al Faisaliah Medical Systems, Bytes Healthcare Solutions, Cerner, Cigna Global Health, EIPICO , GMC, Honeywell, Roche Group, TIBCO Software

Market Driver

• Increase in government initiatives
• For a full, detailed list, view our report

Market Challenge

• High initial cost
• For a full, detailed list, view our report

Market Trend

• Emergence of mobile health solutions
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 79 pages, “Healthcare IT Market in Saudi Arabia 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Market Segmentation by Product, Adoption of Advanced Technology in Saudi Arabian Healthcare Industry, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4nV

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Sepsis - Pipeline Review, H1 2015, New Report Launched

Sepsis - Pipeline Review, H1 2015 report provides an overview of the Sepsis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Sepsis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sepsis and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publishert’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Publishert’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

• The report provides a snapshot of the global therapeutic landscape of Sepsis
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Sepsis and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Sepsis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Sepsis pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products

Reasons to buy

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Sepsis
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Sepsis pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Spanning over 194 pages, “Sepsis - Pipeline Review, H1 2015” report covers the Introduction, Sepsis Overview, Therapeutics Development, Drug Profiles, Appendix. The report covered companies are - Adrenomed AG, Altor BioScience Corporation, Am-Pharma B.V., Arch Biopartners, Inc., Asahi Kasei Pharma Corp., Baxter International Inc., Biomedica Management Corporation, Chiesi Farmaceutici SpA, Chiome Bioscience, Inc., Cilian AG, Cognosci, Inc.

For further information on this report, please visit- http://mrr.cm/4nm

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Relapsed Multiple Myeloma - Pipeline Review, H1 2015, New Report Launched

Relapsed Multiple Myeloma - Pipeline Review, H1 2015 report provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Relapsed Multiple Myeloma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Relapsed Multiple Myeloma and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publishert’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Publishert’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

• The report provides a snapshot of the global therapeutic landscape of Relapsed Multiple Myeloma
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Relapsed Multiple Myeloma and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Relapsed Multiple Myeloma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Relapsed Multiple Myeloma pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products

Reasons to buy

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Relapsed Multiple Myeloma
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Relapsed Multiple Myeloma pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Spanning over 438 pages, “Relapsed Multiple Myeloma - Pipeline Review, H1 2015” report covers the Introduction, Relapsed Multiple Myeloma Overview, Therapeutics Development, Drug Profiles, Appendix. The report covered companies are - 4SC AG, AB Science, AbbVie Inc., Acceleron Pharma, Inc., Acetylon Pharmaceuticals, Inc., Altor BioScience Corporation, Arno Therapeutics, Inc., Array BioPharma Inc., Astellas Pharma Inc., Astex Pharmaceuticals, Inc., Biotest AG, Bristol-Myers Squibb Company, Celgene Corporation

For further information on this report, please visit- http://mrr.cm/4ne

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases

Ischemic Stroke - Pipeline Review, H1 2015, New Report Launched

Ischemic Stroke - Pipeline Review, H1 2015 report provides an overview of the Ischemic Stroke’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemic Stroke and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publishert’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Publishert’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

• The report provides a snapshot of the global therapeutic landscape of Ischemic Stroke
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Ischemic Stroke and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Ischemic Stroke products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Ischemic Stroke pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products

Reasons to buy

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Ischemic Stroke
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Ischemic Stroke pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Spanning over 281 pages, “Ischemic Stroke - Pipeline Review, H1 2015” report covers the Introduction, Ischemic Stroke Overview, Drug Profiles, Appendix. The report covered companies are - AB Science, Acorda Therapeutics, Inc., Acticor Biotech, advanceCor GmbH, AGY Therapeutics, Inc., Angion Biomedica Corp., AstraZeneca PLC, Athersys, Inc., Biogen Idec Inc., BioTime, Inc.

For further information on this report, please visit- http://mrr.cm/4nW

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2015, New Report Launched

Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2015 report provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publishert’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Publishert’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

• The report provides a snapshot of the global therapeutic landscape of Interstitial Cystitis (Painful Bladder Syndrome)
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Interstitial Cystitis (Painful Bladder Syndrome) and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Interstitial Cystitis (Painful Bladder Syndrome) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• A detailed assessment of monotherapy and combination therapy pipeline projects
• Coverage of the Interstitial Cystitis (Painful Bladder Syndrome) pipeline on the basis of target, MoA, route of administration and molecule type
• Latest news and deals relating related to pipeline products

Reasons to buy

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Interstitial Cystitis (Painful Bladder Syndrome)
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Interstitial Cystitis (Painful Bladder Syndrome) pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Spanning over 67 pages, “Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2015” report covers the Introduction, Interstitial Cystitis (Painful Bladder Syndrome) Overview, Interstitial Cystitis (Painful Bladder Syndrome) Overview, Therapeutics Development, Drug Profiles, Appendix. The report covered companies are - Afferent Pharmaceuticals, Inc., Allergan, Inc., Aquinox Pharmaceuticals Inc., Kytogenics Pharmaceuticals, Inc., Lipella Pharmaceuticals, Inc., Qu Biologics Inc., Urigen Pharmaceuticals, Inc.

For further information on this report, please visit- http://mrr.cm/4nh

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases

Global Robotic Surgery Market to grow at a CAGR of 10.66%over the period 2014-2019; Finds New Report

Report forecast the global robotic surgery market to grow at a CAGR of 10.66% over the period 2014-2019.

Robotic surgery or robot-assisted surgery is an MIS procedure that utilizes very small tools attached to a robotic arm to perform the surgery. Robot-assisted surgery offers broader visualization of the operating area and precision control of surgical instruments. In a robotic surgery procedure, a surgeon visualizes the operative field with the help of video monitor and uses a console to control the robotics arms, which performs the procedure. The main aim of robotic surgery is to reduce patients stay in hospital by reducing the pain and scarring associated with surgery to facilitate faster recovery.

The global robotic surgery market can be segmented based on products and services: instruments and accessories, robotic surgical systems, and services.

According to the report, minimally invasive surgeries have revolutionized surgery, as they reduce hospital stay, recovery time, and postoperative pain. Surgeons often use robotics to perform complicated minimally invasive procedures because they allow for the precise movement of instruments and give a better view of the area undergoing surgery compared to other techniques. For this reason, robotic surgeries are preferred over traditional open surgeries and are rapidly replacing them in areas such as gynecology and urology.

The Global Robotic Surgery Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas
• APAC
• EMEA       

Key players in the global robotic surgery market: Intuitive Surgical, Hansen Medical, Mako Surgical (Acquired by Stryker)

Other Prominent Vendors in the market are: Accuray, Medrobotics, Titan Medicals and Stereotaxis

Market Driver

• Increase in Minimally Invasive Procedures
• For a full, detailed list, view our report

Market Challenge

• High Initial Investment
• For a full, detailed list, view our report

Market Trend

• Growth of Economies in APAC
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 61 pages, “Global Robotic Surgery Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Economic Analysis of Robotic Surgery, Market Segmentation by Application, Market Segmentation by Products and Services, Key Takeaway, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4n6

Find all Robotics Reports at: http://www.marketresearchreports.com/robotics

Global Optical Imaging Market to grow at a CAGR of 8.06% over the period 2014-2019; Finds New Report

Report forecast the global optical imaging market to grow at a CAGR of 8.06% over the period 2014-2019.

Optical imaging is a non-invasive technique and is helpful in diagnosing the body by using the visible light and non- ionization radiation. Non-ionization radiation includes visible, UV, and infrared light, which reduces patient exposure to harmful radiation and generates images by exciting electrons. Optical imaging can be combined with MRI and X-rays to provide the enhanced information for doctors and researchers. Also, optical imaging is particularly useful for visualizing organs, tissues, and smaller structures including cells and even molecules that can be distinguished from one another.

The report covers the present scenario and the growth prospects of the global optical imaging market for the period 2015-2019. The market can be segmented based on technology: OCT, hyper spectral imaging, near-infrared spectroscopy, and photoacoustic tomography

According to the report, currently, optical imaging techniques are used during radiosurgery to diagnose various conditions such as disorders of the central nervous system by radiosurgery and surgical procedures to treat intracranial tumors and arteriovenous malformations. Breast and cardiac diseases can also be easily diagnosed with optical imaging. These techniques can accurately depict molecular activity in the body and, as such, can potentially detect a disease in its infancy. Screening high-risk populations and detecting cancer early are crucial for cancer prevention and treatment, respectively. Optical imaging devices can also help gauge individuals' responses to therapy, allowing doctors to determine the best course of treatment.

The Global Optical Imaging Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas
• APAC
• EMEA

Key players in the global optical imaging market: Bioptigen, Carl Zeiss Meditec, Optovue and Topcon Medical Systems

Other Prominent Vendors in the market are: Bruker, Canon, ChemImage, Corning, Endra life sciences, Headwall Photonics, Heidelberg Engineering, Michelson Diagnostics, Miltenyi Biotec, Nidek, PANalytical, Santec, Spectral Instruments Imaging, St. Jude Medical, Thermo Fisher Scientific and Thorlabs

Market Driver

• Ability to Detect Molecular Activity in Early Stage
• For a full, detailed list, view our report

Market Challenge

• Business and Regulatory Challenges
• For a full, detailed list, view our report

Market Trend

• Initiatives toward Increasing Customer Base
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 63 pages, “Global Optical Imaging Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Market Segmentation by Application, Market Segmentation by Technology, Market Segmentation by End-user, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4nX

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Global Bioinformatics Market to grow at a CAGR of 19.49%over the period 2014-2019; Finds New Report

Report forecast the global bioinformatics market to grow at a CAGR of 19.49% over the period 2014-2019.

Bioinformatics is a field of science that includes computational analysis of biological data, which consists of information stored in DNA form and protein sequences in various biological databases. Biology, information technology, and computer science merge into single discipline in bioinformatics. This field is deep rooted in molecular biology and surrounds subject areas from structural biology, genomics to gene expression studies. Bioinformatics is commonly used for identifying SNPs and candidate genes. Bioinformatics analysis focuses on three data set types: macromolecular structures, genome sequences, and functional genomics experiments.

The global bioinformatics market can be divided into three segments: platforms, tools, and services. To calculate the market size, the report considers the revenue generated from the three geographies: Americas, EMEA, and APAC.

According to the report, modern molecular diagnostic techniques, such as in situ hybridization, DNA microarrays, mass spectrometry, NGS, and capillary electrophoresis, are used to detect and quantify DNA or RNA sequences and proteins. These methodologies aid physicians in the early diagnosis of diseases and improve clinical outcomes. The complex molecular diagnostics assays can be simplified by integrating molecular methods with advanced IT and data analytics. In addition, the use of nanotechnology to develop molecular diagnostics will increase the efficiency of protocols.

Global Bioinformatics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas
• APAC
• EMEA       

Key players in the global bioinformatics market: Affymetrix, Agilent Technologies, Dassault Systemes and QIAGEN

Other Prominent Vendors in the market are: Applied Maths, Astrid Research, Biobase, BioDiscovery, Biomax Informatics, Cerner, DNASTAR, Genedata, GeneTalk, Genialis, Genomatix, Genomodel, Genostar, IBM, Ingenuity Systems, IntegraGen, Integromics, MacVector, Ocimum Bio Solutions, PREMIER Biosoft International, Qlucore, Roche Diagnostics, SimBioSys, SRA International, Strand Life sciences, TCS and Thermo Fischer Scientific (Invitrogen)

Market Driver

• Rapid Developments in Molecular Diagnostics
• For a full, detailed list, view our report

Market Challenge

• Lack of Skilled Professionals
• For a full, detailed list, view our report

Market Trend

• Increased Focus on Bioinformatics
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 76 pages, “Global Bioinformatics Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Bioinformatics Overview, Market Landscape, Market Segmentation by Application, Market Segmentation by Product, Geographical Segmentation, Key Focus Countries, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4nf

Find all IT and eHealth Reports at: http://www.marketresearchreports.com/it-ehealth